Direct hemoperfusion with polymyxin B immobilized fiber for abdominal sepsis in Europe

Surgery Today

Volumn 41, Issue 6, 2011, Pages 754-760

  Sato, Koichi ^a   Maekawa, Hiroshi ^a   Sakurada, Mutsumi ^a   Orita, Hajime ^a   Komatsu, Yoshihiro ^a  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

Author keywords

Direct hemoperfusion; Meta analysis; PMX DHP; Polymyxin B immobilized fiber; Randomized controlled trial; Toraymyxin

Indexed keywords

DOBUTAMINE; DOPAMINE; ENDOTOXIN; POLYMYXIN B;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL STUDY; DISEASE SEVERITY; EUROPE; EVIDENCE BASED MEDICINE; EXTRACORPOREAL OXYGENATION; GEOGRAPHIC DISTRIBUTION; HEMODYNAMICS; HEMOPERFUSION; HUMAN; IMMOBILIZED CELL; INTERMETHOD COMPARISON; MEAN ARTERIAL PRESSURE; MORTALITY; PILOT STUDY; PRACTICE GUIDELINE; PRESSOR RESPONSE; SCORING SYSTEM; SEPSIS; STRATEGIC PLANNING; SURVIVAL TIME; SYSTEMATIC REVIEW;

ABDOMEN; ANTI-BACTERIAL AGENTS; ENDOTOXINS; EUROPE; HEMOPERFUSION; HUMANS; META-ANALYSIS AS TOPIC; POLYMYXIN B; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS;

EID: 79960302935     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-010-4504-9     Document Type: Article

References (58)

1. D. Angus R. Wax 2001 Epidemiology of sepsis: an update Crit Care Med 29 7suppl S109 S116 11445744 10.1097/00003246-200107001-00035 1:STN:280: DC%2BD3MzptVykuw%3D%3D
2. J. Marshall D. Foster J. Vincent D. Cook J. Cohen R. Dellinger, et al. 2004 Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study J Infect Dis 190 527 534 15243928 10.1086/422254 1:CAS:528:DC%2BD2cXmvF2ntrc%3D (Pubitemid 38982092)
3. S. Manchu D. Feinstein A. Kumar A. Kumar 2002 Novel therapies for sepsis: antiendotoxin therapies Expert Opin Investig Drugs 11 1795 1812 10.1517/13543784.11.12.1795 (Pubitemid 35469923)
4. E.J. Ziegler C.J. Fisher Jr. C.L. Sprung R.C. Straube J.C. Sadoff G.E. Foulke, et al. 1991 Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial N Engl J Med 324 429 436 1988827 10.1056/ NEJM199102143240701 1:STN:280:DyaK3M7gvFyisg%3D%3D
5. R.V. McCloskey R.C. Straube C. Sanders S.M. Smith C.R. Smith 1994 Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial Ann Intern Med 121 1 5 8198341 1:STN:280:DyaK2c3ls1OhsQ%3D%3D
6. H. Shoji 2003 Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin) Ther Apher Dial 7 108 114 12921125 10.1046/j.1526-0968.2003.00005.x 1:CAS:528:DC%2BD3sXlsFCjsLw%3D (Pubitemid 36648053)
7. T. Nakamura C. Ushiyama Y. Suzuki T. Inoue H. Shoji N. Shimada, et al. 2003 Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillinresistant staphylococcus aureus J Hosp Infect 53 58 63 12495686 10.1053/jhin.2002.1332 1:STN:280:DC%2BD38jjtl2lsQ%3D%3D (Pubitemid 38002089)
8. T. Nakamura Y. Kawagoe T. Matsuda Y. Ueda H. Koide 2004 Effects of polymyxin B-immobilized fiber on urinary N-acetyl-B-glucosaminidase in patients with severe sepsis ASAIO J 50 563 567 15672789 10.1097/01.MAT.0000142875.62592. 3A 1:CAS:528:DC%2BD2cXhtVCisbrI (Pubitemid 39612527)
9. T. Nakamura I. Ebihara H. Shoji C. Ushiyama S. Suzuki H. Koide 1999 Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor-4 and betathromboglobulin Inflamm Res 48 171 175 10344466 10.1007/s000110050442 1:CAS:528:DyaK1MXis1Oku7s%3D (Pubitemid 29192518)
10. T. Nakamura C. Ushiyama Y. Suzuki H. Shoji N. Shimada H. Koide 2002 Hemoperfusion with polymyxin-B immobilized fiber for urinary albumin excretion in septic patients with trauma ASAIO J 48 244 248 12058997 10.1097/00002480- 200205000-00008 1:CAS:528:DC%2BD38XntVKisrw%3D (Pubitemid 35006986)
11. T. Nakamura C. Ushiyama Y. Suzuki S. Osada T. Inoue H. Shoji, et al. 2003 Hemoperfusion with polymyxin-B immobilized fiber in septic patients with methicillin-resistant staphylococcus aureusassociated glomerulonephritis Nephron Clin Pract 94 c33 c39 12845235 10.1159/000071279 1:CAS:528:DC%2BD3sXltlChtbo%3D
12. T. Nakamura Y. Kawagoe T. Matsuda H. Koide 2004 Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis Intensive Care Med 30 1838 1841 15197430 10.1007/s00134-004-2357-7 (Pubitemid 39297191)
13. H. Nemoto H. Nakamoto H. Okada S. Sugahara K. Moriwaki M. Arai, et al. 2001 Newly developed polymyxin B-immobilized fibers improve the survival of patients with sepsis Blood Purif 19 361 369 11574732 10.1159/000046966 1:CAS:528:DC%2BD3MXntV2mtr0%3D (Pubitemid 34701465)
14. H. Suzuki H. Nemoto H. Nakamoto H. Okada S. Sugahara Y. Kanno, et al. 2002 Continuous hemodiafiltration with polymyxin B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure Ther Apher 6 234 240 12109950 10.1046/j.1526-0968.2002.00416.x 1:CAS:528:DC%2BD38XlslOhtrc%3D (Pubitemid 34753568)
15. T. Nakamura I. Ebihara N. Shimada S. Suzuki C. Ushiyama H. Shoji, et al. 1998 Effects of hemoperfusion with polymyxin Bimmobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock J Infect 37 241 247 9892527 10.1016/S0163-4453(98)91952-1 1:STN:280:DyaK1M7gslGntw%3D%3D (Pubitemid 29017270)
16. T. Nakamura I. Ebihara N. Shimada H. Koide 1998 Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion and polymyxin B immobilized fiber Intensive Care Med 24 1272 1276 9885879 10.1007/s001340050761 1:STN:280:DyaK1M7gtV2ksg%3D%3D (Pubitemid 28564449)
17. T. Nakamura Y. Kawagoe T. Matsuda H. Shoji Y. Ueda N. Tamura, et al. 2004 Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients Blood Purif 22 256 260 15148453 10.1159/000078494 1:CAS:528: DC%2BD2cXmtlSmtbs%3D (Pubitemid 39177729)
18. T. Nakamura Y. Kawagoe T. Sukuzi H. Shoji Y. Ueda N. Kobayashi, et al. 2005 Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock Blood Purif 23 417 420 16141713 10.1159/000088016 1:CAS:528:DC%2BD2MXhtlahsr%2FE (Pubitemid 41816067)
19. N. Shimada T. Nakamura Y. Takayashi A. Tanaka H. Shoji K. Sekizuka, et al. 2000 Effects of polymyxin B-immobilized fiber on serum phosphate concentrations in patients with sepsis Nephron 86 359 360 11096302 10.1159/000045800 1:STN:280:DC%2BD3M%2FmtV2nsw%3D%3D
20. T. Tani K. Hanasawa Y. Endo T. Yoshioka M. Kodama M. Kaneko, et al. 1998 Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin-B immobilized column Artif Organs 22 1038 1044 9876096 10.1046/j.1525-1594.1998.06086.x 1:STN:280:DyaK1M%2FptFehtg%3D%3D (Pubitemid 28564161)
21. T. Tojimbara S. Sato I. Nakajima S. Fuchinoue T. Akiba S. Teraoka 2004 Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure Ther Apher Dial 8 286 292 15274679 10.1111/j.1526-0968.2004.00166.x 1:CAS:528:DC%2BD2cXnvVyjuro%3D (Pubitemid 39108745)
22. T. Ueno M. Sugino H. Nemoto H. Shoji A. Kakita M. Watanabe 2005 Effect over time of endotoxin adsorption therapy in sepsis Ther Apher Dial 9 128 136 15828924 10.1111/j.1774-9987.2005.00230.x 1:CAS:528:DC%2BD2MXlsFejtr0%3D (Pubitemid 40734774)
23. K. Uriu A. Osajima M. Kamochi H. Watanabe K. Aibara K. Kaizu 2002 Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock Am J Kidney Dis 39 937 947 11979337 10.1053/ajkd.2002.32767 1:CAS:528:DC%2BD38XktFWms7k%3D (Pubitemid 34454212)
24. M. Kodama T. Tani K. Hanasawa K. Hirata H. Hirasawa S. Oda, et al. 1997 Treatment of sepsis by plasma endotoxin removal: hemoperfusion using a polymyxin-B immobilized column Innate Immun 4 293 300 10.1177/096805199700400407 1:CAS:528:DyaK2sXotVOgt7w%3D (Pubitemid 27490355)
25. G. Novelli G. Ferretti L. Poli R. Pretagostini F. Ruberto S.M. Perrella, et al. 2010 Clinical results of treatment of postsurgical endotoxinmediated sepsis with polymyxin-B direct hemoperfusion Transplant Proc 42 1021 1024 20534214 10.1016/j.transproceed.2010.03.056 1:CAS:528:DC%2BC3cXmslelsLY%3D
26. C. Mitaka N. Tsuchida K. Kamada N. Nakajima T. Imai S. Sasaki 2009 A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock Shock 32 478 483 19295483 10.1097/SHK.0b013e3181a2a978 1:CAS:528:DC%2BD1MXht1KisL3N
27. T. Kumagai N. Takeyama T. Yabuki M. Harada Y. Miki H. Kanou, et al. 2010 Apheresis of activated leukocytes with an immobilized polymyxin B filter in septic patients Shock 34 461 466 20386499 10.1097/SHK.0b013e3181e14ca0 1:CAS:528:DC%2BC3cXhtlWjsL3L
28. H. Nemoto H. Nakamoto H. Okada S. Sugahara K. Moriwaki M. Arai, et al. 2001 Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis Blood Purif 19 361 368 11574732 10.1159/000046966 1:CAS:528:DC%2BD3MXntV2mtr0%3D (Pubitemid 34701465)
29. Ueno T, Ikeda K, Ikeda K, Taniuchi H, Suda S, Yeung MY, et al. HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP. J Surg Res 2009 [Epub ahead of print]. PMID: 20338589.
30. H. Wang O. Bloom M. Zhang J.M. Vishnubhakat M. Ombrellino J. Che, et al. 1999 HMG-1 as a late mediator of endotoxin lethality in mice Science 285 248 251 10398600 10.1126/science.285.5425.248 1:CAS:528:DyaK1MXks1Sjtb0%3D (Pubitemid 29329996)
31. K. Suda H. Takeuchi A. Ishizaka Y. Kitagawa 2010 High-mobility-group box chromosomal protein 1 as a new target for modulating stress response Surg Today 40 592 601 20582508 10.1007/s00595-009-4232-1 1:CAS:528:DC%2BC3cXotVKnsLg%3D
32. H. Yang M. Ochani J. Li X. Qiang M. Tanovic H.E. Harris, et al. 2004 Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc Natl Acad Sci USA 101 296 301 14695889 10.1073/pnas.2434651100 1:CAS:528:DC%2BD2cXjvFamtA%3D%3D (Pubitemid 38084244)
33. K. Suda Y. Kitagawa S. Ozawa Y. Saikawa M. Ueda M. Ebina, et al. 2006 Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis World J Surg 30 1755 1762 16850155 10.1007/s00268-005-0369-2 (Pubitemid 44411235)
34. H. Ueno T. Matsuda S. Hashimoto F. Amaya Y. Kitamura M. Tanaka, et al. 2004 Contributions of high mobility group box protein in experimental and clinical acute lung injury Am J Respir Crit Care Med 170 1310 1316 15374839 10.1164/rccm.200402-188OC (Pubitemid 39657195)
35. Y. Sakamoto K. Mashiko H. Matsumoto Y. Hara N. Kutsukata Y. Yamamoto 2007 Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients ASAIO J 53 324 328 17515723 10.1097/MAT.0b013e3180340301 1:CAS:528:DC%2BD2sXlt1Cgur8%3D (Pubitemid 46791540)
36. J.L. Vincent P.F. Laterre J. Cohen H. Burchardi H. Bruining F.A. Lerma, et al. 2005 A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection Shock 23 400 405 15834304 10.1097/01.shk.0000159930.87737.8a 1:CAS:528:DC%2BD2MXltVKhsLY%3D (Pubitemid 40571661)
37. J. Cohen J.S. McConnell 1984 Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay J Infect Dis 150 916 924 6501933 10.1093/infdis/150.6.916 1:CAS:528:DyaL2MXktFSltw%3D%3D (Pubitemid 15182149)
38. D.N. Cruz M.A. Perazella R. Bellomo M. de Cal N. Polanco V. Corradi, et al. 2007 Effectiveness of polymyxin B-immobilized fiber column in sepsis; a systematic review Crit Care 11 R47 17448226 10.1186/cc5780 (Pubitemid 46805281)
39. S. Ono H. Tsujinomoto A. Matsumoto S. Ikuta M. Kinoshita H. Michizuki 2004 Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with polymyxin B immobilized fiber Am J Surg 188 150 156 15249240 10.1016/j.amjsurg.2003.12.067 1:CAS:528:DC%2BD2cXlsFymtL8%3D (Pubitemid 38916733)
40. H. Tsujimoto S. Ono S. Hiraki T. Majima N. Kawarabayashi H. Sugasawa, et al. 2004 Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+CD14+ monocytes in patients with septic shock J Endotoxin Res 10 229 237 15373966 1:CAS:528:DC%2BD2cXhtVyitrvI (Pubitemid 39481012)
41. K. Tsushima K. Kubo T. Koizumi H. Yamamoto K. Fujimoto K. Hora, et al. 2002 Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory J Clin Apheresis 17 97 102 12210714 10.1002/jca.10019 (Pubitemid 34809559)
42. T. Ikeda K. Ikeda M. Nagura H. Taniuchi M. Matsushita S. Kiuchi, et al. 2004 Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure Ther Apher Dial 8 293 298 15274680 10.1111/j.1526-0968. 2004.00167.x 1:CAS:528:DC%2BD2cXnvVyjurs%3D (Pubitemid 39108746)
43. M. Kojika N. Sato Y. Yaegashi Y. Suzuki K. Suzuki H. Nakae, et al. 2006 Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity Ther Apher Dial 10 12 18 16556131 10.1111/j.1744-9987.2006.00340.x 1:CAS:528:DC%2BD28XksVyhsrc%3D
44. G. Casella G. Monti V. Terzi M. Pulici A. Ravizza S. Vesconi 2006 Nonconventional therapies in refractory septic shock: clinical experience with polymyxin B (in Italian) Minerva Anestesiol 72 suppl1 63 67
45. H. Kushi T. Miki K. Okamoto J. Nakahara T. Saito K. Tanjoh 2005 Early haemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation Crit Care 9 R653 R661 16280061 10.1186/cc3815
46. T. Nakamura T. Matsuda Y. Suzuki H. Shoji H. Koide 2003 Polymyxin B-immobilized fiber in patient with sepsis Dial Transplant 32 602 607
47. K. Tsugawa N. Koyanagi M. Hashizume H. Wada K. Ayukawa K. Akahoshi, et al. 2002 Results of endotoxin absorption after a subtotal resection of the small intestine and a right hemicolectomy for severe superior mesenteric ischemia Hepatogastroenterology 49 1303 1306 12239931
48. A.R. Jadad R.A. Moore D. Carroll C. Jenkinson D.J. Reynolds D.J. Gavaghan, et al. 1996 Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 12 8721797 10.1016/0197-2456(95)00134-4 1:STN:280:DyaK28zgvVCmug%3D%3D (Pubitemid 26120810)
49. D.N. Cruz M. Antonelli R. Fumagalli F. Foltran N. Brienza A. Donati, et al. 2009 Early use of polymyxin B hemoperfusion in abdominal septic shock. The EUPHAS randomized controlled trial JAMA 301 2445 2452 19531784 10.1001/jama.2009.856 1:CAS:528:DC%2BD1MXnsFaqsLY%3D
50. R.P. Dellinger J.M. Carlet H. Masur H. Gerlach T. Calandra J. Cohen, et al. 2004 Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Intensive Care Med 30 536 555 14997291 10.1007/s00134-004-2398- y (Pubitemid 38541501)
51. J.L. Vincent R. Moreno J. Takala S. Willatts A.D. Mendonça H. Bruininget, et al. 1996 The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine Intensive Care Med 22 707 710 8844239 10.1007/BF01709751 1:STN:280: DyaK2s%2FgtFantQ%3D%3D
52. S. Shore D.P. Nelson J.M. Pearl P.B. Manning H. Wong T.P. Shanley, et al. 2001 Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease Am J Cardiol 88 591 594 11524081 10.1016/S0002-9149(01)01751-9 1:CAS:528: DC%2BD3MXmt1Klu7s%3D (Pubitemid 32778518)
53. G. Wernovsky D. Wypij R.A. Jonas J.E. Mayer Jr. F.L. Hanley P.R. Hickey, et al. 1995 Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest Circulation 92 2226 2235 7554206 1:STN:280:DyaK28%2FhslejsA%3D%3D
54. A.F. Zuppa V. Nadkarni L. Davis P.C. Adamson M.A. Helfaer M.R. Elliott, et al. 2004 The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function Crit Care Med 32 2318 2322 15640648 1:CAS:528:DC%2BD2cXpsl2jtr0%3D (Pubitemid 39491815)
55. H. Tsujimoto S. Ono S. Hiraki T. Majima N. Kawarabayashi H. Sugasawa, et al. 2004 Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+CD14+ monocytes in patients with septic shock J Endotoxin Res 10 229 237 15373966 1:CAS:528:DC%2BD2cXhtVyitrvI (Pubitemid 39481012)
56. J.L. Vincent 2009 Polymyxin B hemoperfusion and mortality in abdominal septic shock JAMA 302 1968 19903915 10.1001/jama.2009.1606 1:CAS:528: DC%2BD1MXhsVWmsbvI
57. A.C.K.B. Amaral 2009 Polymyxin B hemoperfusion and mortality in abdominal septic shock JAMA 302 1968 1969 19903914 10.1001/jama.2009.1607 1:CAS:528:DC%2BD1MXhsVWmsbvJ
58. M. Antonelli F. Giunta C. Ronco 2009 Polymyxin B hemoperfusion and mortality in abdominal septic shock JAMA 302 1969 1970 10.1001/jama.2009.1609 1:CAS:528:DC%2BD1MXhsVWmsbvL